Singapore, May 31, 2010: China Sky One Medical said that its Tian Long Pharmaceutical Company subsidiary successfully obtained renewal of its Good Manufacturing Practices (GMP) certificate for pharmaceutical products from the State Food and Drug Administration (SFDA) in China. The new certificate will be valid until May 2015.

According to the National Medicine Administration Law of China, all pharmaceutical manufacturers are required to renew their GMP Certificates every five years.

 

SFDA's examination committee visited Tian Long in April this year to review its supply chain management practices, including quality control system test, inspect its GMP management process, production records for its five production lines, quality test record and laboratory management.

“Given the extensive scope of the inspection and examination, we are very proud to pass the examination in just one round and successfully renewed the GMP Certificate for Tian Long,” said Mr Yan-qing Liu, Chairman and CEO of China Sky One Medical.